GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » EV-to-Revenue

Bcworldpharm Co (XKRX:200780) EV-to-Revenue : 1.85 (As of May. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bcworldpharm Co's enterprise value is ₩133,582 Mil. Bcworldpharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩72,195 Mil. Therefore, Bcworldpharm Co's EV-to-Revenue for today is 1.85.

The historical rank and industry rank for Bcworldpharm Co's EV-to-Revenue or its related term are showing as below:

XKRX:200780' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.62   Med: 3.65   Max: 7.3
Current: 1.78

During the past 11 years, the highest EV-to-Revenue of Bcworldpharm Co was 7.30. The lowest was 1.62. And the median was 3.65.

XKRX:200780's EV-to-Revenue is ranked better than
61.79% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.335 vs XKRX:200780: 1.78

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-22), Bcworldpharm Co's stock price is ₩6120.00. Bcworldpharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩8,555.76. Therefore, Bcworldpharm Co's PS Ratio for today is 0.72.


Bcworldpharm Co EV-to-Revenue Historical Data

The historical data trend for Bcworldpharm Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co EV-to-Revenue Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.21 3.30 3.51 2.14 1.78

Bcworldpharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 1.84 1.79 1.78 -

Competitive Comparison of Bcworldpharm Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's EV-to-Revenue falls into.



Bcworldpharm Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bcworldpharm Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=133581.653/72195.006
=1.85

Bcworldpharm Co's current Enterprise Value is ₩133,582 Mil.
Bcworldpharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩72,195 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bcworldpharm Co  (XKRX:200780) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bcworldpharm Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6120.00/8555.756
=0.72

Bcworldpharm Co's share price for today is ₩6120.00.
Bcworldpharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,555.76.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bcworldpharm Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co (XKRX:200780) Business Description

Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co (XKRX:200780) Headlines

No Headlines